Immunogenicity, molecular profiling and safety of a marketed quadrivalent influenza vaccine (FluQuadriTM) administered by the intramuscular route in participants 60 years of age and older - INCENTIVE: QIV-1
Latest Information Update: 27 Nov 2020
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms INCENTIVE: QIV-1
- 27 Nov 2020 New trial record